GAIN Act Spurs Roche to Expand Focus on Antibacterials Research

Clinical Trials Advisor
A A
Swiss drugmaker Roche plans to partner with Swiss-owned Polyphor to develop a drug that targets a leading cause of hospital-borne infections.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00